Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2008 3
2009 1
2010 1
2011 2
2012 7
2013 3
2014 2
2015 3
2016 3
2017 1
2018 2
2019 6
2020 3
2021 2
2022 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sumo hirata (1 results)?
Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version.
Usui J, Yamagata K, Imai E, Okuyama H, Kajiyama H, Kanamori H, Kaneko S, Kono E, Sakai Y, Sakai N, Sakamaki Y, Taniguchi Y, Nakai K, Nishiwaki H, Hirata S, Yamaya H, Tsuruoka S, Terada Y, Yokoyama H, Wada T, Narita I. Usui J, et al. Among authors: hirata s. Clin Exp Nephrol. 2016 Dec;20(6):827-831. doi: 10.1007/s10157-016-1334-0. Clin Exp Nephrol. 2016. PMID: 27714545 Free PMC article. Review. No abstract available.
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K, Fujiwara Y, Hanafusa N, Hatta T, Hoshino J, Ichioka S, Inoue T, Ishikura K, Kato T, Kitamura H, Kobayashi Y, Koizumi Y, Kondoh C, Matsubara T, Matsubara K, Matsumoto K, Okuda Y, Okumura Y, Sakaida E, Shibagaki Y, Shimodaira H, Takano N, Uchida A, Yakushijin K, Yamamoto T, Yamamoto K, Yasuda Y, Oya M, Okada H, Nangaku M, Kashihara N. Yanagita M, et al. Among authors: hirata s. Clin Exp Nephrol. 2024 Feb;28(2):85-122. doi: 10.1007/s10157-023-02415-0. Epub 2023 Oct 25. Clin Exp Nephrol. 2024. PMID: 37878114 Free PMC article. No abstract available.
[Management of Chronic Kidney Disease in Cancer Survivors].
Kondoh C, Ishikura K, Ichioka S, Omae K, Okuda Y, Koitabashi K, Sasaki A, Suyama K, Tanizawa M, Mizukami T, Shibagaki Y, Hirata S, Ando Y, Furuichi K, Nishiyama H, Matsubara T, Hoshino J, Yanagita M. Kondoh C, et al. Among authors: hirata s. Gan To Kagaku Ryoho. 2022 Nov;49(11):1200-1204. Gan To Kagaku Ryoho. 2022. PMID: 36412020 Japanese.
In vivo evaluation of drug dialyzability in a rat model of hemodialysis.
Fukunaga M, Kadowaki D, Mori M, Hagiwara S, Narita Y, Saruwatari J, Tanaka R, Watanabe H, Yamasaki K, Taguchi K, Ito H, Maruyama T, Otagiri M, Hirata S. Fukunaga M, et al. Among authors: hirata s. PLoS One. 2020 Jun 12;15(6):e0233925. doi: 10.1371/journal.pone.0233925. eCollection 2020. PLoS One. 2020. PMID: 32530952 Free PMC article.
Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022.
Ishikura K, Omae K, Sasaki S, Shibagaki Y, Ichioka S, Okuda Y, Koitabashi K, Suyama K, Mizukami T, Kondoh C, Hirata S, Matsubara T, Hoshino J, Yanagita M. Ishikura K, et al. Among authors: hirata s. Int J Clin Oncol. 2023 Oct;28(10):1333-1342. doi: 10.1007/s10147-023-02375-1. Epub 2023 Jul 7. Int J Clin Oncol. 2023. PMID: 37418141
46 results